Literature DB >> 6969087

Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice.

A Gabizon, N Trainin.   

Abstract

The effect of lymphocytes from normal mice on the growth of a syngeneic, radiation-induced, T-cell-derived lymphoma was investigated. Thymus and spleen cells enhanced the growth of admixed lymphoma cells in a reproducible manner. Growth enhancement was manifested by the earlier appearance and higher final incidence of tumours. Lymphocytes also enhanced the growth of radiation-damaged lymphoma cells. The enhancing activity of spleen cells was predominantly a property of T cells, since it was abolished by treatment with anti-theta serum plus complement and significantly less in spleen cells of nude mice. Tumour-enhancing thymocytes seem to belong to the immature thymic subpopulation, as indicated by their binding to peanut agglutinin.

Entities:  

Mesh:

Year:  1980        PMID: 6969087      PMCID: PMC2010444          DOI: 10.1038/bjc.1980.279

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor.

Authors:  M Small; N Trainin
Journal:  Int J Cancer       Date:  1975-06-15       Impact factor: 7.396

2.  Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes.

Authors:  T Umiel; N Trainin
Journal:  Transplantation       Date:  1974-09       Impact factor: 4.939

3.  EnhancemenT of 3LL tumor growth by autosensitized t lymphocytes independent of the host lymphatic system.

Authors:  C Carnaud; D Ilfeld; Y Levo; N Trainin
Journal:  Int J Cancer       Date:  1974-08-15       Impact factor: 7.396

4.  In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro.

Authors:  D Ilfeld; C Carnaud; I R Cohen; N Trainin
Journal:  Int J Cancer       Date:  1973-07-15       Impact factor: 7.396

5.  In vitro studies of cellular-mediated immunostimulation of tumor growth.

Authors:  I J Fidler
Journal:  J Natl Cancer Inst       Date:  1973-05       Impact factor: 13.506

6.  Immune stimulation-inhibition of experimental cancer metastasis.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1974-03       Impact factor: 12.701

7.  Effects of intercellular contact on repair of radiation damage.

Authors:  R E Durand; R M Sutherland
Journal:  Exp Cell Res       Date:  1972-03       Impact factor: 3.905

8.  Facilitation of tumor growth by syngeneic normal cells mixed with tumor cells in vitro.

Authors:  P J Deckers; K P Ramming; Y H Pilch
Journal:  Cancer       Date:  1971-04       Impact factor: 6.860

9.  Mouse thymic iso-antigens.

Authors:  A E Reif; J M Allen
Journal:  Nature       Date:  1966-01-29       Impact factor: 49.962

10.  The immune reaction as a stimulator of tumor growth.

Authors:  R T Prehn
Journal:  Science       Date:  1972-04-14       Impact factor: 47.728

View more
  4 in total

1.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Authors:  D Papahadjopoulos; T M Allen; A Gabizon; E Mayhew; K Matthay; S K Huang; K D Lee; M C Woodle; D D Lasic; C Redemann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Authors:  A Gabizon; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids.

Authors:  Yuval Avnir; Keren Turjeman; Deborah Tulchinsky; Alex Sigal; Pablo Kizelsztein; Dina Tzemach; Alberto Gabizon; Yechezkel Barenholz
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

4.  Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model.

Authors:  A Gabizon; D Goren; Z Fuks; A Meshorer; Y Barenholz
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.